Please login to the form below

Not currently logged in

pharma acquisition

This page shows the latest pharma acquisition news and features for those working in and with pharma, biotech and healthcare.

Pfizer adds Array to cancer arsenal with $11bn acquisition

Pfizer adds Array to cancer arsenal with $11bn acquisition

The acquisition announced yesterday is the big pharma company's largest since it bought another oncology specialist, Medivation in 2016 for $14bn, and could help build a third cancer blockbuster franchise ... Analysts at Evaluate Pharma forecast

Latest news

More from news
Approximately 10 fully matching, plus 79 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Acquisition. $244m. Zealand/. Royalty Pharma. Royalty streams and milestones for Soliqua 100/33/. ... So two opportunities here – acquisition of animal health products and out-licensing to Bayer’s pharma business.

  • The good, the bad and the ugly The good, the bad and the ugly

    The company hopes its $12bn acquisition of Kite Pharma (August 2017) will help it steal a march on the lucrative CAR-T market through its treatment for advanced lymphoma. ... The data this article was based on is available in full online:

  • Pharma deals continue to slide Pharma deals continue to slide

    Given big pharma’s reluctance to spend on M&A it is perhaps surprising that this month Gilead has announced the $11.9bn acquisition of Kite Pharma. ... 175+ (upfront 75). Weifa (NO). Karo Pharma (SE). Company acquisition. Karo acquires Norwegian OTC

  • Deal Watch - May 2017 Deal Watch - May 2017

    Stada (pharma). 4, 350. Apax. Company acquisition. Syneron (aesthetic devices). 397. ... Gurnet Point. Company acquisition. Innocoll (pharma). 209. Capital International. Minority share.

  • Deal Watch February 2017 Deal Watch February 2017

    Other pharma companies divesting assets this month include Janssen/J&J and Sanofi. ... It is apparently eyeing a potential acquisition of the CRO PPD for around $8bn.

More from intelligence
Approximately 0 fully matching, plus 36 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Mergers and acquisitions: agents for change

    Getting the best from your agency in a disruptive time. Multi-billion dollar mergers and acquisitions have always created headlines in pharma news, and it’s fair to say that the ... We have supported clients in the run up to the merger or acquisition

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....